(Q72092500)
Statements
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients (English)
M de Forni
R Bugat
G G Chabot
S Culine
J M Extra
A Gouyette
I Madelaine
M E Marty